Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Puma Biotechnology (PBYI) Shares Issued (2017 - 2024)

Puma Biotechnology's Shares Issued history spans 6 years, with the latest figure at $150000.0 for Q3 2024.

  • For Q3 2024, Shares Issued changed N/A year-over-year to $150000.0; the TTM value through Dec 2025 reached $150000.0, changed 0.0%, while the annual FY2025 figure was $130000.0, 13.33% down from the prior year.
  • Shares Issued reached $150000.0 in Q3 2024 per PBYI's latest filing, up from -$10.0 million in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $10.0 million in Q1 2022 to a low of -$10.0 million in Q4 2022.
  • Average Shares Issued over 3 years is $29600.0, with a median of $43000.0 recorded in 2020.
  • The largest YoY upside for Shares Issued was 43.42% in 2020 against a maximum downside of 4400.0% in 2020.
  • A 3-year view of Shares Issued shows it stood at -$45000.0 in 2020, then crashed by 22122.22% to -$10.0 million in 2022, then surged by 101.5% to $150000.0 in 2024.
  • Per Business Quant, the three most recent readings for PBYI's Shares Issued are $150000.0 (Q3 2024), -$10.0 million (Q4 2022), and $10.0 million (Q1 2022).